WallStreetZenWallStreetZen

NASDAQ: FBRX
Forte Biosciences Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for FBRX

Based on 2 analysts offering 12 month price targets for Forte Biosciences Inc

Min Forecast
$61.00+410.03%
Avg Forecast
$68.00+468.56%
Max Forecast
$75.00+527.09%

Should I buy or sell FBRX stock?

Based on 2 analysts offering ratings for Forte Biosciences Inc.

Strong Buy
Strong Buy
2 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although FBRX's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates FBRX as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their FBRX stock forecasts and price targets.

FBRX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-08-18
lockedlocked$00.00+00.00%2025-08-15

1 of 1

Forecast return on equity

Is FBRX forecast to generate an efficient return?

Company
-23.32%
Industry
130.14%
Market
-52.51%
FBRX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is FBRX forecast to generate an efficient return on assets?

Company
-21.34%
Industry
47.48%
FBRX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

FBRX earnings per share forecast

What is FBRX's earnings per share in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$4.45
Avg 2 year Forecast
-$3.48
Avg 3 year Forecast
-$2.05

FBRX revenue forecast

What is FBRX's revenue in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
$129.8M
Avg 2 year Forecast
$264.7M

FBRX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
FBRX$11.96$68.00+468.56%Strong Buy
AVTX$11.33$24.75+118.45%Strong Buy
PLX$1.87N/AN/A
GNLX$3.91$21.00+437.08%Strong Buy
ELDN$2.43$9.00+270.37%Buy
View Top Biotech Stocks

Forte Biosciences Stock Forecast FAQ

Is Forte Biosciences Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: FBRX) stock is to Strong Buy FBRX stock.

Out of 2 analysts, 2 (100%) are recommending FBRX as a Strong Buy, 0 (0%) are recommending FBRX as a Buy, 0 (0%) are recommending FBRX as a Hold, 0 (0%) are recommending FBRX as a Sell, and 0 (0%) are recommending FBRX as a Strong Sell.

If you're new to stock investing, here's how to buy Forte Biosciences stock.

What is FBRX's earnings growth forecast for 2025-2027?

(NASDAQ: FBRX) Forte Biosciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 5.13%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.2%.

Forte Biosciences's earnings in 2025 is -$42,452,000.On average, 3 Wall Street analysts forecast FBRX's earnings for 2025 to be -$55,285,172, with the lowest FBRX earnings forecast at -$62,164,270, and the highest FBRX earnings forecast at -$50,104,402. On average, 3 Wall Street analysts forecast FBRX's earnings for 2026 to be -$43,307,360, with the lowest FBRX earnings forecast at -$51,596,344, and the highest FBRX earnings forecast at -$30,584,821.

In 2027, FBRX is forecast to generate -$25,487,351 in earnings, with the lowest earnings forecast at -$25,487,351 and the highest earnings forecast at -$25,487,351.

What is FBRX's revenue growth forecast for 2029-2030?

(NASDAQ: FBRX) Forte Biosciences's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 83.67%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.8%.

Forte Biosciences's revenue in 2025 is $0.On average, 1 Wall Street analysts forecast FBRX's revenue for 2029 to be $1,613,287,135, with the lowest FBRX revenue forecast at $1,613,287,135, and the highest FBRX revenue forecast at $1,613,287,135.

In 2030, FBRX is forecast to generate $3,291,100,782 in revenue, with the lowest revenue forecast at $3,291,100,782 and the highest revenue forecast at $3,291,100,782.

What is FBRX's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: FBRX) forecast ROA is -21.34%, which is lower than the forecast US Biotechnology industry average of 47.48%.

What is FBRX's Price Target?

According to 2 Wall Street analysts that have issued a 1 year FBRX price target, the average FBRX price target is $68.00, with the highest FBRX stock price forecast at $75.00 and the lowest FBRX stock price forecast at $61.00.

On average, Wall Street analysts predict that Forte Biosciences's share price could reach $68.00 by Aug 18, 2026. The average Forte Biosciences stock price prediction forecasts a potential upside of 468.56% from the current FBRX share price of $11.96.

What is FBRX's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: FBRX) Forte Biosciences's current Earnings Per Share (EPS) is -$3.69. On average, analysts forecast that FBRX's EPS will be -$4.45 for 2025, with the lowest EPS forecast at -$5.00, and the highest EPS forecast at -$4.03. On average, analysts forecast that FBRX's EPS will be -$3.48 for 2026, with the lowest EPS forecast at -$4.15, and the highest EPS forecast at -$2.46. In 2027, FBRX's EPS is forecast to hit -$2.05 (min: -$2.05, max: -$2.05).

What is FBRX's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: FBRX) forecast ROE is -23.32%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.